Fereydoun G Sajjadi

Title: Fereydoun G Sajjadi: Innovator in Cancer Research

Introduction

Fereydoun G Sajjadi is a notable inventor based in San Diego, CA. He has made significant contributions to the field of cancer research through his innovative work on Eph-related protein tyrosine kinases. His research focuses on the molecular mechanisms involved in cancer diagnosis and prognosis.

Latest Patents

Fereydoun G Sajjadi holds a patent for "Eph-related tyrosine kinases, nucleotide sequences and methods of use." This invention is directed to substantially purified Eph-related protein tyrosine kinases, or functional fragments thereof, which exhibit about 23 to 66 percent amino acid sequence identity in their carboxyl terminal variable regions compared to known members of the Eph subclass of tyrosine kinases. The patent also includes nucleic acids encoding such Eph-related protein tyrosine kinases, vectors, and host cells. Furthermore, the invention outlines a method for diagnosing cancer and determining cancer prognosis by analyzing the level of Eph-related protein tyrosine kinase in tissue or cell samples.

Career Highlights

Fereydoun G Sajjadi is affiliated with the La Jolla Cancer Research Foundation, where he continues to advance his research in cancer biology. His work has the potential to significantly impact cancer diagnostics and treatment strategies.

Collaborations

Fereydoun collaborates with Elena B Pasquale, a fellow researcher in the field. Their combined expertise contributes to the ongoing efforts in understanding cancer mechanisms and developing innovative diagnostic methods.

Conclusion

Fereydoun G Sajjadi's contributions to cancer research through his patented innovations highlight the importance of scientific inquiry in improving health outcomes. His work exemplifies the critical role of inventors in advancing medical science and technology.